Biotech Intelligence for Agile Teams

We focus on what companies do, not what they say. Trials, regulatory filings, patents, and market data organized to surface signals traditional analysis misses.

Biotech Industry Intelligence Platform

Track biotech pipelines, trial changes, and market movements in one place. Company-first organization, clinical trial change detection, SEC filing analysis, and your research notes connected to live data from trials, filings, and markets.

Explore the Platform →
Clinical trial tracker showing market movements and biotech company data
Mapping the competitive Landscape with clinical trial embeddings

Mapping Competitive Landscapes

Using Form D filings to build a custom fundraising database

Biotech Investment Tracking

Analysis of regulatory impact of FTC Patent challenges

Regulatory Monitoring & Analysis

47,588
FDA-approved drug products
21,155
patent-to-product linkages
24
months of change history

Drug Patent & Exclusivity Data

From $299

Recent Analysis

View all

The Biggest Disclosure Day in Biotech

Brief Report

January 17, 2026

JPM Healthcare opening day triggers more biotech 8-K filings than any other day of the year. Analysis of SEC filing patterns shows 23% of public biotechs tracked by RxDataLab disclose on a single day.

Focused tools for BD, strategy, and research teams

RxDataLab builds focused data tools for BD, strategy, and research teams. We are not another enterprise platform. We aggregate regulatory and market data from primary public sources: clinical trial records, FDA submissions, SEC filings, patent data, and financial disclosures. No news, no sentiment, no spin. Experienced practitioners get precise questions answered with defensible data.

Ready to Talk?

Whether you're evaluating an investment opportunity, conducting due diligence, preparing for fundraising, or tracking competitive intelligence, We can provide the data and technical depth you need.

Get in Touch
Or email directly at [email protected]